Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	37.89B -24.3%
Revenue (ttm)	17.26B -7.2%
Net Income	1.19B -22.1%
EPS	0.87 -22.1%
Shares Out	1.37B
PE Ratio	31.87
Forward PE	29.04
Dividend	1.00 (3.56%)
Ex-Dividend Date	n/a

Volume	6,626,904
Average Volume	6,856,932
Open	28.02
Previous Close	28.08
Day's Range	27.54 - 28.02
52-Week Range	27.50 - 38.36
Beta	0.26
RSI	33.74
Earnings Date	Mar 31, 2026

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverag...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,883
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2025, Beijing Tongrentang's revenue was 17.26 billion, a decrease of -7.21% compared to the previous year's 18.60 billion. Earnings were 1.19 billion, a decrease of -22.07%.